Claims for Patent: 10,220,155
✉ Email this page to a colleague
Summary for Patent: 10,220,155
| Title: | Syringe device with a dose limiting mechanism and an additional safety mechanism |
| Abstract: | A syringe device for ejecting a dose of a medicament, the syringe device comprising: a dose limiting mechanism arranged to interact with a dose ejecting mechanism to prevent ejection of a dose exceeding a set dose, and a safety mechanism, which is arranged such with respect to the dose ejecting mechanism that, if the dose limiting mechanism fails, the safety mechanism prevents ejection of a dose exceeding the set dose. |
| Inventor(s): | Eiland Jacob, Enggaard Christian Peter, Moller Claus Schmidt, Markussen Tom Hede |
| Assignee: | Novo Nordisk A/S |
| Application Number: | US11996397 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,220,155 |
| Patent Claims: |
Details for Patent 10,220,155
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Novo Nordisk Inc. | LEVEMIR | insulin detemir | Injection | 021536 | June 16, 2005 | 10,220,155 | 2026-07-17 |
| Novo Nordisk Inc. | LEVEMIR | insulin detemir | Injection | 021536 | October 31, 2013 | 10,220,155 | 2026-07-17 |
| Novo Nordisk Inc. | NOVOLOG MIX 50/50 | insulin aspart protamine and insulin aspart | Injectable Suspension | 021810 | August 26, 2008 | 10,220,155 | 2026-07-17 |
| Seqirus Inc. | FLUAD | influenza vaccine, adjuvanted | Injection | 125510 | November 24, 2015 | 10,220,155 | 2026-07-17 |
| Seqirus Inc. | FLUAD,FLUAD QUADRIVALENT | influenza vaccine, adjuvanted | Injection | 125510 | February 21, 2020 | 10,220,155 | 2026-07-17 |
| Novo Nordisk Inc. | TRESIBA | insulin degludec | Injection | 203314 | September 25, 2015 | 10,220,155 | 2026-07-17 |
| Novo Nordisk Inc. | TRESIBA | insulin degludec | Injection | 203314 | November 21, 2018 | 10,220,155 | 2026-07-17 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,220,155
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007017053 | ⤷ Get Started Free |
| United States of America | 2025195784 | ⤷ Get Started Free |
| United States of America | 2021346606 | ⤷ Get Started Free |
| United States of America | 2019192783 | ⤷ Get Started Free |
| United States of America | 2008234634 | ⤷ Get Started Free |
| United States of America | 12268854 | ⤷ Get Started Free |
| United States of America | 11097063 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch